Cambridge Investment Research Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.34M Sell
58,051
-9,529
-14% -$1.21M 0.02% 676
2025
Q1
$8.64M Sell
67,580
-1,650
-2% -$211K 0.03% 562
2024
Q4
$9.15M Buy
69,230
+518
+0.8% +$68.5K 0.03% 523
2024
Q3
$10M Sell
68,712
-9,979
-13% -$1.45M 0.03% 500
2024
Q2
$10.8M Sell
78,691
-5,538
-7% -$760K 0.04% 435
2024
Q1
$11.6M Buy
84,229
+47
+0.1% +$6.45K 0.04% 400
2023
Q4
$11.4M Sell
84,182
-3,507
-4% -$476K 0.05% 361
2023
Q3
$10.7M Buy
87,689
+8,162
+10% +$998K 0.05% 358
2023
Q2
$10.1M Sell
79,527
-7,614
-9% -$967K 0.05% 384
2023
Q1
$11.3M Sell
87,141
-8,841
-9% -$1.14M 0.06% 340
2022
Q4
$12.6M Sell
95,982
-1,875
-2% -$246K 0.07% 300
2022
Q3
$11.4M Sell
97,857
-7,454
-7% -$872K 0.06% 292
2022
Q2
$12.4M Sell
105,311
-738
-0.7% -$86.8K 0.07% 283
2022
Q1
$13.8M Sell
106,049
-21,995
-17% -$2.87M 0.06% 294
2021
Q4
$19.5M Buy
128,044
+7,138
+6% +$1.09M 0.09% 221
2021
Q3
$19.5M Sell
120,906
-15,553
-11% -$2.51M 0.1% 208
2021
Q2
$22.3M Buy
136,459
+9,778
+8% +$1.6M 0.11% 200
2021
Q1
$19.1M Sell
126,681
-1,278
-1% -$192K 0.1% 204
2020
Q4
$19.4M Sell
127,959
-651
-0.5% -$98.6K 0.11% 183
2020
Q3
$17.4M Sell
128,610
-8,712
-6% -$1.18M 0.12% 182
2020
Q2
$18.8M Buy
137,322
+82,779
+152% +$11.3M 0.14% 150
2020
Q1
$5.88M Sell
54,543
-14,629
-21% -$1.58M 0.06% 313
2019
Q4
$8.34M Sell
69,172
-16,986
-20% -$2.05M 0.06% 296
2019
Q3
$8.57M Buy
86,158
+11,463
+15% +$1.14M 0.08% 263
2019
Q2
$8.15M Sell
74,695
-7,784
-9% -$849K 0.07% 262
2019
Q1
$9.22M Buy
82,479
+18,359
+29% +$2.05M 0.09% 221
2018
Q4
$6.18M Sell
64,120
-4,825
-7% -$465K 0.07% 264
2018
Q3
$8.41M Sell
68,945
-3,941
-5% -$481K 0.08% 244
2018
Q2
$8M Sell
72,886
-2,302
-3% -$253K 0.08% 231
2018
Q1
$8.03M Buy
75,188
+3,053
+4% +$326K 0.09% 217
2017
Q4
$7.7M Sell
72,135
-5,178
-7% -$553K 0.09% 213
2017
Q3
$8.6M Buy
77,313
+4,362
+6% +$485K 0.12% 163
2017
Q2
$7.54M Buy
72,951
+5,733
+9% +$593K 0.11% 166
2017
Q1
$6.57M Buy
67,218
+10,248
+18% +$1M 0.11% 169
2016
Q4
$5.04M Sell
56,970
-4,443
-7% -$393K 0.09% 204
2016
Q3
$5.93M Buy
61,413
+15,207
+33% +$1.47M 0.11% 165
2016
Q2
$3.96M Buy
46,206
+2,013
+5% +$173K 0.08% 227
2016
Q1
$3.84M Buy
44,193
+5,100
+13% +$443K 0.09% 212
2015
Q4
$4.41M Buy
39,093
+6,213
+19% +$701K 0.1% 183
2015
Q3
$3.33M Sell
32,880
-16,113
-33% -$1.63M 0.1% 209
2015
Q2
$6.03M Sell
48,993
-714
-1% -$87.8K 0.17% 129
2015
Q1
$5.69M Buy
49,707
+7,818
+19% +$895K 0.16% 130
2014
Q4
$4.24M Buy
41,889
+7,236
+21% +$732K 0.13% 155
2014
Q3
$3.16M Buy
34,653
+1,707
+5% +$156K 0.09% 208
2014
Q2
$2.82M Buy
32,946
+747
+2% +$64K 0.1% 201
2014
Q1
$2.54M Buy
32,199
+2,376
+8% +$187K 0.1% 199
2013
Q4
$2.26M Buy
29,823
+294
+1% +$22.3K 0.09% 200
2013
Q3
$2.06M Buy
29,529
+3,243
+12% +$227K 0.09% 211
2013
Q2
$1.52M Buy
+26,286
New +$1.52M 0.08% 236